An analysis of a separate cohort of 124 adult patients with AML found that low levels of EZH2 expression, which corresponded with reduced levels of H3K27me3, correlated strongly with poor overall and event-free survival. The gene discussed is EZH2; the disease is acute myeloid leukemia.